Synopsys (SNPS) closed the most recent trading day at $601.55, moving -1.33% from the previous trading session. This change lagged the S&P 500's daily gain of 0.4%. Meanwhile, the Dow experienced a ...

A nascent hypothesis regarding pulmonary arterial hypertension (PAH) is that there is a link between thyroid dysfunction and PAH risk; much remains to be investigated to prove causality.

Shares of Synopsys Inc. SNPS slid 1.33% to $601.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.40% to 6,388.64 and ...

Synopsys (SNPS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Bipolar disorder is a mental health condition characterized by extreme mood swings, with alternating periods of depression ...

This study reveals how machine learning models uncover new genetic variants linked to Alzheimer’s, advancing predictive ...

Shares of Synopsys Inc. SNPS rose 1.15% to $591.46 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.14% to 6,305.60 and the ...

Buying $1000 In SNPS: If an investor had bought $1000 of SNPS stock 15 years ago, it would be worth $26,611.09 today based on a price of $587.59 for SNPS at the time of writing.

A team of researchers has developed the first high-resolution genetic map and a versatile SNP chip for Panax ginseng, a ...

The recently passed One Big Beautiful Bill Act (OBBBA) could have a disproportionate impact on nursing home residents ...

Unraveling the genetic mechanisms behind adaptive evolution stands as a pivotal challenge in molecular biology. While ...

Digital advertising company The Trade Desk is joining the benchmark index today, S&P Dow Jones Indices has said.